Physician
Chen, Eric
Chen, Eric was paid $487K by Medicaid between Oct 2020 and Dec 2022, across 30 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 31% of everything it billed.
33Billing provider infoCHEN, ERIC
LONGVIEW, TX 75601
LONGVIEW, TX 75601
33aNPI1891716510assigned 07/21/2006
33bProvider typeNeonatal-Perinatal Medicine Physician
28Total paid$487K
24GClaims18,795
24DCodes billed30
24AFirst – last monthOct 2020 – Dec 2022
Compared with peers
Next to other Neonatal-Perinatal Medicine Physician providers in Texas
Rank by total paid#12 of 37
Median peer was paid$139K
This provider vs. median3.5×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2020 | 1,480 | $29K | |
| 2021 | 9,365 | $235K | |
| 2022 | 7,950 | $223K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 31% | 4,195 | 3,665 | $151K |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | 14% | 866 | 863 | $68K |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | 13% | 760 | 753 | $63K |
| 87811 | Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) | 9.0% | 1,119 | 1,064 | $44K |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | 8.2% | 525 | 524 | $40K |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | 5.7% | 305 | 305 | $28K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 3.8% | 1,358 | 664 | $19K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 3.7% | 1,310 | 1,275 | $18K |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | 3.7% | 2,070 | 2,059 | $18K |
| 90472 | Immunization administration, each additional vaccine (list separately) | 3.4% | 1,707 | 1,077 | $17K |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | 2.1% | 1,261 | 1,001 | $10K |
| 87807 | <1% | 430 | 416 | $5K |
18 more codes
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | <1% | 46 | $4K |
| 90474 | <1% | 266 | $2K | |
| 99381 | <1% | 14 | $1K | |
| 90686 | <1% | 942 | $0.02 | |
| 90680 | 0% | 268 | $0.00 | |
| 90723 | 0% | 76 | $0.00 | |
| 90716 | 0% | 28 | $0.00 | |
| 90647 | 0% | 66 | $0.00 | |
| 90651 | 0% | 61 | $0.00 | |
| 90696 | 0% | 37 | $0.00 | |
| 90734 | 0% | 69 | $0.00 | |
| 90700 | 0% | 137 | $0.00 | |
| 90715 | 0% | 25 | $0.00 | |
| 90633 | 0% | 222 | $0.00 | |
| 90648 | 0% | 84 | $0.00 | |
| 90707 | 0% | 29 | $0.00 | |
| 90670 | 0% | 507 | $0.00 | |
| 90710 | 0% | 12 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.